GlaxoSmithKline Market and Forecasts, May 2012

GlaxoSmithKline - Company Report for Year 2011

• Company report
• January 2011
• 2 pages

... Registrant : organisation or self-employed individual name/company name: glaxosmithkline acronym: gsk legal status: corporation website address: - sections section: ii - in ...

• Industries: Pathology
• Countries: United Kingdom, Europe, World

GlaxoSmithKline - Company Report for Year 2011

• Company report
• January 2011
• 3 pages

... Of the organisation: glaxosmithkline (gsk) is a research-based pharmaceutical company. Our mission is to improve the quality of human life by enabling people to do more, feel better and live longer. This mission gives ...

• Industries: Pathology
• Countries: United Kingdom, Europe, Belgium

GlaxoSmithKline - Investment Analysis, March 2011

• Company report
• March 2011
• 5 pages

... Cagr to rs8.1Bn. Maintain reduce on the stock with a target price of rs1914. At cmp, the stock is trading at 28x/ 25x cy11/ 12e earnings respectively. glaxosmithkline pharma result update emkay ...

• Industries: Drug and Medication
• Countries: India, World

GlaxoSmithKline - Forward Looking Presentation for Year 2011

• Company report
• December 2011
• 38 pages

... Chart recommendation Buy Target price: $56.21 Questions Sources bloomberg terminal "glaxosmithkline company report." Ibis world. 2011. Web. 1 Dec. 2011. "glaxosmithkline q3 profit." Rttnews ...

• Industries: Pharmaceutical
• Countries: World

GlaxoSmithKline - Company Report for Year 2011

• Company report
• June 2011
• 17 pages

... Top ten holdings as at 30.06.11 Percentage of net assets % glaxosmithkline 7.35 Babcock international 5.01 Bp 4.83 Melrose 4.23 Reed elsevier 3.86 Rsa insurance 3.62 Howden joinery 3.35 Bg 3 ...

GlaxoSmithKline - Company Report for Year 2011

• Company report
• March 2011
• 16 pages
• by Corporation

... Based pharmaceutical and healthcare companies Is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.Gsk.Com glaxosmithkline ...

• Industries: Drug and Medication
• Countries: United States

GlaxoSmithKline - Company Report for Year 2012

• Company report
• February 2012
• 6 pages

... Limited liability company (formerly smithkline beecham corporation) d/b/a glaxosmithkline ("gsk"), arising out of purchases made through www.Gskvaccinesdirect.Com (the "gsk direct website"). Before ...

• Industries: Drug and Medication
• Countries: United States

The United States: Brief Outlook, 2011-2012, focus on Plastic

• Country report
• November 2011
• 2 pages

... The investment in a unique industry alliance with pharmaceutical manufactu glaxosmithkline to produce parts for respiratory inhalers. The announcement marks the firm S second significant expansion in the past ...

• Industries: Plastic
• Countries: United States

Company Report: Vaccine in India for Year 2011

• Company report
• December 2011
• 2 pages

... General meeting, the dividend will absorb rs. 381 Crores. The dividend distribution tax borne by the company will amount to rs. 60 Crores. About glaxosmithkline: glaxosmithkline pharmaceuticals ...

• Industries: Drug and Medication
• Countries: India

The United States: Brief Outlook, 2011-2013

• Country report
• March 2011
• 2 pages

... To-suit trend as they will construct glaxosmithkline S new four-story, $80 million, philadelphia headquarters. Liberty property trust recently announced plans to build the university of pennsylvania S new ...

• Countries: United States